[go: up one dir, main page]

GB0513778D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0513778D0
GB0513778D0 GB0513778A GB0513778A GB0513778D0 GB 0513778 D0 GB0513778 D0 GB 0513778D0 GB 0513778 A GB0513778 A GB 0513778A GB 0513778 A GB0513778 A GB 0513778A GB 0513778 D0 GB0513778 D0 GB 0513778D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0513778A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0513778A priority Critical patent/GB0513778D0/en
Publication of GB0513778D0 publication Critical patent/GB0513778D0/en
Priority to AU2006264620A priority patent/AU2006264620B2/en
Priority to CA002614002A priority patent/CA2614002A1/en
Priority to US11/994,824 priority patent/US20090176731A1/en
Priority to JP2008519988A priority patent/JP2009500384A/en
Priority to PCT/GB2006/002462 priority patent/WO2007003933A2/en
Priority to BRPI0612397-0A priority patent/BRPI0612397A2/en
Priority to EP06755701A priority patent/EP1901754A2/en
Priority to NZ564189A priority patent/NZ564189A/en
Priority to KR1020087002092A priority patent/KR20080031029A/en
Priority to CN2006800245799A priority patent/CN101217966B/en
Priority to MX2007016497A priority patent/MX2007016497A/en
Priority to ZA200710913A priority patent/ZA200710913B/en
Priority to NO20076657A priority patent/NO20076657L/en
Priority to IL188513A priority patent/IL188513A0/en
Ceased legal-status Critical Current

Links

GB0513778A 2005-07-06 2005-07-06 Combination therapy Ceased GB0513778D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB0513778A GB0513778D0 (en) 2005-07-06 2005-07-06 Combination therapy
MX2007016497A MX2007016497A (en) 2005-07-06 2006-07-03 Combination therapy.
BRPI0612397-0A BRPI0612397A2 (en) 2005-07-06 2006-07-03 use of azd2171 or a pharmaceutically acceptable salt thereof and gemcitabine, pharmaceutical composition, kit, and method for producing an anti-angiogenic and / or vascular permeability reducing effect in a warm-blooded animal
NZ564189A NZ564189A (en) 2005-07-06 2006-07-03 Combination therapy of cancer with AZD2171 and gemcitabine
US11/994,824 US20090176731A1 (en) 2005-07-06 2006-07-03 Combination therapy of cancer with azd2171 and gemcitabine
JP2008519988A JP2009500384A (en) 2005-07-06 2006-07-03 Combination therapy
PCT/GB2006/002462 WO2007003933A2 (en) 2005-07-06 2006-07-03 Combination therapy of cancer with azd2171 and gemcitabine
AU2006264620A AU2006264620B2 (en) 2005-07-06 2006-07-03 Combination therapy of cancer with AZD2171 and gemcitabine
EP06755701A EP1901754A2 (en) 2005-07-06 2006-07-03 Combination therapy of cancer with azd2171 and gemcitabine
CA002614002A CA2614002A1 (en) 2005-07-06 2006-07-03 Combination therapy of cancer with azd2171 and gemcitabine
KR1020087002092A KR20080031029A (en) 2005-07-06 2006-07-03 Combination Therapy of Cancer with ASD2171 and Gemcitabine
CN2006800245799A CN101217966B (en) 2005-07-06 2006-07-03 Use of the combination of AZD2171 and gemcitabine in the preparation of medicines for treating cancer
ZA200710913A ZA200710913B (en) 2005-07-06 2007-12-14 Combination therapy of cancer with AZD2171 and gemcitabine
NO20076657A NO20076657L (en) 2005-07-06 2007-12-28 Combination therapy of cancer with AZD2171 and gemcitabine
IL188513A IL188513A0 (en) 2005-07-06 2007-12-31 Combination therapy of cancer with azd2171 and gemcitabine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0513778A GB0513778D0 (en) 2005-07-06 2005-07-06 Combination therapy

Publications (1)

Publication Number Publication Date
GB0513778D0 true GB0513778D0 (en) 2005-08-10

Family

ID=34856705

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0513778A Ceased GB0513778D0 (en) 2005-07-06 2005-07-06 Combination therapy

Country Status (3)

Country Link
CN (1) CN101217966B (en)
GB (1) GB0513778D0 (en)
ZA (1) ZA200710913B (en)

Also Published As

Publication number Publication date
ZA200710913B (en) 2008-12-31
CN101217966B (en) 2011-02-02
CN101217966A (en) 2008-07-09

Similar Documents

Publication Publication Date Title
GB0506147D0 (en) Therapeutic agents
PL1877096T3 (en) Non-lithotripsic kidney-stone therapy
GB0428180D0 (en) Combination therapy
GB0417481D0 (en) Combination therapy
GB0505437D0 (en) Therapeutic agents
GB0505725D0 (en) Therapeutic agents
ZA200709627B (en) Combination therapy
GB0519350D0 (en) Therapeutic agents
GB0518819D0 (en) Therapeutic agents
GB0504206D0 (en) Combination therapy
GB0424339D0 (en) Combination therapy
GB0518817D0 (en) Therapeutic agents
GB0509052D0 (en) Combination therapy
GB0516661D0 (en) Therapeutic agents
GB0514738D0 (en) Therapeutic agents
GB0507003D0 (en) Therapeutic
GB0518720D0 (en) Therapeutic combination
GB0501655D0 (en) Therapeutic use
GB0421436D0 (en) Combination therapy
GB0421438D0 (en) Combination therapy
GB0513778D0 (en) Combination therapy
GB0526132D0 (en) Combination Therapy
GB0526121D0 (en) Combination therapy
GB0514347D0 (en) Combination therapy
GB0506726D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)